Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-12-16 20:29:53
Reporting Period:
Accepted Time:
2020-12-16 20:29:53
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1598646 Minerva Neurosciences Inc. NERV Pharmaceutical Preparations (2834) 260784194
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1610384 Remy Luthringer C/o Minerva Neurosciences, Inc.
1601 Trapelo Road, Suite 286
Waltham MA 02451
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-14 18,750 $0.00 67,790 No 4 M Direct
Common Stock Disposition 2020-12-16 1,300 $2.64 66,490 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2020-12-14 18,750 $0.00 18,750 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 926,604 Indirect By Wint2felden Holding SA
  1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants.
  3. Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date.